Directory
>
Mark Nowakowski
Mark Nowakowski
Venture Partner | Argonaut Manufacturing Services Inc.
San Diego, California, United States
Mark Nowakowski
Summary
Mark Nowakowski is a seasoned professional in the field of scientific research and development services, with a robust background in biotechnology and molecular diagnostics. Currently serving as a Board Member and Venture Partner, he leverages his extensive experience in assay development and infectious diseases to drive innovation and growth in his ventures. Mark has a proven track record in leadership roles, including Chief Technology Officer and Chief Executive Officer, where he has successfully led teams in the commercialization of advanced diagnostic technologies. His entrepreneurial spirit is evident from his founding role at Lyogen, where he pioneered new approaches in the industry. With a Master's degree in R&D Systems Management from the University of Southern California, he combines academic knowledge with practical expertise. Mark's diverse experience spans across various organizations, from startups to established firms, showcasing his adaptability and strategic vision in the fast-evolving biotech landscape.
Mark Nowakowski
Work Experience
Venture Partner at
PHASE TWO VENTURES (PTY) LTD
May 2023 - Present
Board Member at
Argonaut Manufacturing Services Inc.
March 2023 - Present
Scientific Advisor at
Defined Bioscience, Inc.
July 2021 - Present
Chief Technology Officer at
Argonaut Manufacturing Services Inc.
July 2018 - March 2024
Chief Executive Officer and Founder at
Lyogen LLC
October 2011 - July 2018
Chief Operating Officer at
Mesa Biotech, Inc.
October 2011 - March 2016
Principal Development Engineer and Founder at
Biomatrix Engineering
January 1998 - November 2011
Principal Development Engineer at
Fmc Bioproducts
January 1992 - January 1997
Director of Engineering at
Biosite Diagnostics
October 1987 - October 1992
Sr. Engineer at
Hybritech
January 1985 - January 1987
Mark Nowakowski
Education
University of Southern California, Ms In R&D Systems Management
January 1983 - January 1985
Frequently Asked Questions about Mark Nowakowski
What is Mark Nowakowski email address?
Mark Nowakowski's primary email address is *****@usa.net. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mark Nowakowski work for?
Mark Nowakowski is a Venture Partner at Argonaut Manufacturing Services Inc., a company specializing in Commercial physical research.
Where Mark Nowakowski graduated from?
Mark Nowakowski holds a degree in from University of Southern California.
How can I directly contact Mark Nowakowski?
To contact Mark Nowakowski directly, you can use the email address *****@usa.net. Complete contact information is available upon registration with Muraena.
Who is Mark Nowakowski?
Mark Nowakowski is a seasoned professional in the field of scientific research and development services, with a robust background in biotechnology and molecular diagnostics. Currently serving as a Board Member and Venture Partner, he leverages his extensive experience in assay development and infectious diseases to drive innovation and growth in his ventures. Mark has a proven track record in leadership roles, including Chief Technology Officer and Chief Executive Officer, where he has successfully led teams in the commercialization of advanced diagnostic technologies. His entrepreneurial spirit is evident from his founding role at Lyogen, where he pioneered new approaches in the industry. With a Master's degree in R&D Systems Management from the University of Southern California, he combines academic knowledge with practical expertise. Mark's diverse experience spans across various organizations, from startups to established firms, showcasing his adaptability and strategic vision in the fast-evolving biotech landscape.
Mark`s contact details
*****@usa.net
****@argonautms.com
Colleagues
Senior Vice President & General Manager of Life Sciences
CFO
Vice President, Quality and Regulatory
Vice President Strategic Partnerships
Vice President Strategic Partnerships
SVP & General Manager, Biopharma Services
Chief Executive Officer